Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Efficacy and safety of oral chelators in treatment of patients with Wilson disease.

Weiss KH, Thurik F, Gotthardt DN, Schäfer M, Teufel U, Wiegand F, Merle U, Ferenci-Foerster D, Maieron A, Stauber R, Zoller H, Schmidt HH, Reuner U, Hefter H, Trocello JM, Houwen RH, Ferenci P, Stremmel W; EUROWILSON Consortium.

Clin Gastroenterol Hepatol. 2013 Aug;11(8):1028-35.e1-2. doi: 10.1016/j.cgh.2013.03.012. Epub 2013 Mar 28.

PMID:
23542331
2.

Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease.

Weiss KH, Gotthardt DN, Klemm D, Merle U, Ferenci-Foerster D, Schaefer M, Ferenci P, Stremmel W.

Gastroenterology. 2011 Apr;140(4):1189-1198.e1. doi: 10.1053/j.gastro.2010.12.034. Epub 2010 Dec 24.

PMID:
21185835

Supplemental Content

Loading ...
Support Center